Editorial: Therapy in genetic disease.
D000328:Adult; D000917:Antibody Formation; D002554:Cerebrosides / Q000378:metabolism; D002648:Child; D002675:Child, Preschool; D057487:Enzyme Therapy; D000795:Fabry Disease / Q000188:drug therapy / Q000378:metabolism; D005696:Galactosidases / Q000627:therapeutic use; D005776:Gaucher Disease / Q000188:drug therapy / Q000378:metabolism; D005947:Glucose; D005959:Glucosidases / Q000276:immunology / Q000627:therapeutic use; D006801:Humans; D008661:Metabolism, Inborn Errors / Q000188:drug therapy*; D013107:Sphingolipids / Q000378:metabolism
D002554:Cerebrosides; D013107:Sphingolipids; D005696:Galactosidases; D005959:Glucosidases; D005947:Glucose